Immune suppression leading to hepatitis C virus re-emergence after sustained virological response

Journal of Medical Virology

Volumn 80, Issue 10, 2008, Pages 1720-1722

  Lin, Amy ^a   Thadareddy, Anupama ^a   Goldstein, Michael J ^a   Lake Bakaar, Gerond ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hepatitis C virus; Immunity; Sustained virological response

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BRONCHITIS; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION TEST; MALE; POSTOPERATIVE PERIOD; RELAPSE; VIROLOGY; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BRONCHITIS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2A; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECURRENCE; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD; VIREMIA;

HEPATITIS C VIRUS;

EID: 50849095496     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21257     Document Type: Article

References (19)

1. Bassett SE, Guerra B, Brasky K, Miskovsky E, Houghton M, Klimpel GR, Lanford RE. 2001. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33:1479-1487.
2. Borgia G. 2004. Specific immunoglobulin against HCV: New perspectives. IDrugs 7:570-574.
3. Chung RT. 2005. Acute hepatitis C virus infection. Clin Infect Dis 41:S14-S17.
4. Desmond CP, Roberts SK, Dudley F, Mitchell J, Day CL, Nguyen S, Pianko S. 2006. Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting. J Viral Hepat 13:311-315.
5. Garcia-Sastre A, Biron CA. 2006. Type 1 interferons and the virus-host relationship: A lesson in detente. Science 312:879-882.
6. Jiao X, Wang RY, Qiu Q, Alter HJ, Shih JW. 2004. Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes. J Gen Virol 85:1545-1553.
7. Kaplan DE, Sugimoto K, Ikeda F, Stadanlick J, Valiga M, Shetty K, Reddy KR, Chang KM. 2005. T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C. Hepatology 41:1365-1375.
8. Lanford RE, Guerra B, Chavez D, Bigger C, Brasky KM, Wang XH, Ray SC, Thomas DL. 2004. Cross-genotype immunity to hepatitis C virus. J Virol 78:1575-1581.
9. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Robbins GK, Casson DR, Reiser M, Dusheiko G, Allen TM, Chung RT, Walker BD, Klenerman P. 2004. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127:924-936.
10. Lauer GM, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Wiesch JS, Paranhos-Baccala G, Sheridan I, Casson DR, Reiser M, Gandhi RT, Li B, Allen TM, Chung RT, Klenerman P, Walker BD. 2005. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J Virol 79:12979-12988.
11. Lee WM, Polson JE, Carney DS, Sahin B, Gale M Jr. 2005. Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: Evidence for an occult viral reservoir. J Infect Dis 192:1088-1092.
12. McHutchison JG, Davis GL, Esteban-Mur Rea R. 2001. Durability of sustained virologie response in patients with chronic hepatitis C after treatment with interferon alfa-2b alone and in combination with ribavirin. Hepatology 34:244A.
13. Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. 2002. Protection against persistence of hepatitis C. Lancet 359:1478-1483.
14. Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, Feinstone SM, Rehermann B. 2003. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 77:4781-4793.
15. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. 2005. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106-114.
16. Rahman F, Heller T, Sobao Y, Mizukoshi E, Nascimbeni M, Alter H, Herrine S, Hoofnagle J, Liang TJ, Rehermann B. 2004. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 40:87-97.
17. Shoukry NH, Cawthon AG, Walker CM. 2004. Cell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection. Annu Rev Microbiol 58:391-424.
18. Tsuda N, Yuki N, Mochizuki K, Nagaoka T, Yamashiro M, Omura M, Hikiji K, Kato M. 2004. Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy. J Med Virol 74:406-413.
19. Wiegand J, Jackel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Asian N, Tillmann HL, Manns MP, Wedemeyer H. 2004. Long-term follow-up after successful interferon therapy of acute hepatitis C. Hepatology 40:98-107.